Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-08 9:03 pm Sale | 2024-02-29 | 13D | Century Therapeutics, Inc. IPSC | Casdin Capital LLC | 3,206,380 4.950% | -16,560 (-0.51%) | Filing History |
| 2024-03-20 5:25 pm Purchase | 2024-03-18 | 13D | CM LIFE SCIENCES II INC UNIT 1 CMIIU | Casdin Capital LLC | 74,535,666 19.250% | 74,535,666 (New Position) | Filing History |
| 2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | MaxCyte, Inc. MXCT | Casdin Capital LLC | 0 0.000% | -9,220,000 (Position Closed) | Filing History |
| 2024-02-14 4:20 pm Purchase | 2023-12-31 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital LLC | 7,387,943 5.990% | 1,089,369 (+17.30%) | Filing History |
| 2024-01-09 5:13 pm Purchase | 2024-01-05 | 13D | Standard BioTools Inc. LAB | Casdin Capital LLC | 65,297,596 19.710% | 27,715,250 (+73.75%) | Filing History |
| 2023-11-14 6:35 pm Sale | 2023-11-09 | 13D | EQRx, Inc. EQRX | Casdin Capital LLC | 0 0.000% | -56,297,042 (Position Closed) | Filing History |
| 2023-10-24 4:29 pm Purchase | 2023-10-19 | 13D | BioLife Solutions, Inc. BLFS | Casdin Capital LLC | 8,707,165 19.500% | 1,267,058 (+17.03%) | Filing History |
| 2023-10-02 4:14 pm Purchase | 2023-09-21 | 13G | Relay Therapeutics, Inc. RLAY | Casdin Capital LLC | 6,298,574 5.160% | 6,298,574 (New Position) | Filing History |
| 2023-05-08 4:15 pm Sale | 2023-05-04 | 13D | Absci Corporation ABSI | Casdin Capital LLC | 4,448,260 4.800% | -1,085,000 (-19.61%) | Filing History |
| 2023-03-20 4:22 pm Sale | 2023-03-16 | 13D | Absci Corporation ABSI | Casdin Capital LLC | 5,533,260 6.000% | -940,000 (-14.52%) | Filing History |
| 2023-02-13 9:36 pm Sale | 2022-12-31 | 13G | DermTech, Inc. DMTKQ | Casdin Capital LLC | 0 0.000% | -1,745,000 (Position Closed) | Filing History |
| 2023-02-13 9:34 pm Sale | 2022-12-31 | 13G | Tango Therapeutics, Inc. TNGX | Casdin Capital LLC | 0 0.000% | -5,487,910 (Position Closed) | Filing History |
| 2023-02-13 9:34 pm Sale | 2022-12-31 | 13G | Invitae Corporation NVTAQ | Casdin Capital LLC | 9,038,388 3.720% | -3,165,281 (-25.94%) | Filing History |
| 2023-02-13 9:31 pm Sale | 2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA | Casdin Capital LLC | 0 0.000% | -3,901,589 (Position Closed) | Filing History |
| 2023-02-13 9:30 pm Sale | 2022-12-31 | 13G | Codexis, Inc. CDXS | Casdin Capital LLC | 0 0.000% | -4,330,000 (Position Closed) | Filing History |
| 2023-02-13 9:27 pm Sale | 2022-12-31 | 13G | Verve Therapeutics, Inc. VERV | Casdin Capital LLC | 2,290,571 3.700% | -847,596 (-27.01%) | Filing History |
| 2023-02-13 11:53 am Sale | 2023-02-08 | 13D | Absci Corporation ABSI | Casdin Capital LLC | 6,473,260 7.000% | -1,245,333 (-16.13%) | Filing History |
| 2023-01-10 4:48 pm Sale | 2023-01-05 | 13G | MaxCyte, Inc. MXCT | Casdin Capital LLC | 9,220,000 9.020% | -4,751,334 (-34.01%) | Filing History |
| 2022-12-07 1:51 pm Unchanged | 2022-12-05 | 13D | Tenaya Therapeutics, Inc. TNYA | Casdin Capital LLC | 6,427,200 9.900% | 0 (Unchanged) | Filing History |
| 2022-11-29 5:11 pm Purchase | 2022-11-23 | 13D | EQRx, Inc. EQRX | Casdin Capital LLC | 56,297,042 13.000% | 56,297,042 (New Position) | Filing History |